Model NO.: 401900-40-1
Market: Globel
MOQ: 10g
Payment: Western Union, Monygram, Bank Wire
Shipping: Hkems, Feedex, DHL
Trademark: taigui
Origin: China
HS Code: 29163920
Model NO.: 401900-40-1
Market: Globel
MOQ: 10g
Payment: Western Union, Monygram, Bank Wire
Shipping: Hkems, Feedex, DHL
Trademark: taigui
Origin: China
HS Code: 29163920
Bodybuilding Powder Andarine /Â S4Andarine(S4) CAS;1182367-47-0
Andarine(S4) MW:437.94026
Andarine(S4) Appearance:White powder
Andarine(S4) Function:New generation supplements for gaining mass and cutting edges
Andarine(S4) Quality:98% by HPLC
Andarine(S4) Assay:HPLC;HNRM;LC-MS
Andarine(S4) Packaging Detail:10g,50g,100g,500g,1kg in aluminum foil bags
Andarine(S4) Delivery Detail:5-7days for regular shipping
Usage:
Andarine (GTx-007, S-4) is an investigational selective androgen receptor modulator (SARM) developed by GTX, Inc for treatment of conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy, using the non-steroidal androgen antagonist bicalutamide as a lead compound.
Andarine is an orally active partial agonist for androgen receptors. It is less potent in both anabolic and androgenic effects than other SARMs. In an animal model of benign prostatic hypertrophy, andarine was shown to reduce prostate weight with similar efficacy to finasteride, but without producing any reduction in muscle mass or anti-androgenic side effects. This suggests that it is able to competitively block binding of dihydrotestosterone to its receptor targets in the prostate gland, but its partial agonist effects at androgen receptors prevent the side effects associated with the anti-androgenic drugs traditionally used for treatment of BPH.
Information of Andarine (S4) :
Andarine is an orally active partial agonist for androgen receptors, S-4 is effective in not only maintaining lean body mass but actually increasing it. Andarine is less potent in both anabolic and androgenic effects than other SARMs. In an animal model of benign prostatic hypertrophy, andarine was shown to reduce prostate weight with similar efficacy to finasteride, but without producing any reduction in muscle mass or anti-androgenic side effects. This suggests that it is able to competitively block binding to its receptor targets in the prostate gland, but its partial agonist effects at androgen receptors prevent the side effects associated with the anti-androgenic drugs traditionally used for treatment of BPH.
Other SARMs
Â
| Name | CAS NO. | Usage |
| AICAR | 2627-69-2 | acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown |
| MK2866 | 841205-47-8 | medical prescription for prevention of cachexia, atrophy, and sarcopenia and for Hormone or Testoserone Replacement Therapy. |
| MK-677 | 15972-10-0 | Â for the treatment of frailty in the elderly |
| LGD-4033 | 1165910-22-4 | pharmacological profile similar to that of enobosarm, Ostarine,MK-2866 |
| GW1516 | 317318-70-0 | For obesity, diabetes, dyslipidemia and cardiovascular disease |
| Andarine(S4) | 401900-40-0 | partial agonist, intended mainly for treatment of benign prostatic hypertrophy |
| SR9009 | 1379686-30-2 | under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice |
| RAD140 | 1182367-47-0 | New generation for gaining mass and cutting edges |
| YK11 | 431579-34-9 | YK11: a SARM and myostatin inhibitor in one  |
| AC262356 | 870888-46-3 | New SARMS |
| SR9011 | 1379686-29-9 | New SARMS |
| S23 | 1010396-29-8 | New SARMS |
| GW0724 | 317318-84-6 | New SARMS |
 Bodybuilding Powder Andarine / S4
Andarine(S4) CAS;1182367-47-0
Andarine(S4) MW:437.94026
Andarine(S4) Appearance:White powder
Andarine(S4) Function:New generation supplements for gaining mass and cutting edges
Andarine(S4) Quality:98% by HPLC
Andarine(S4) Assay:HPLC;HNRM;LC-MS
Andarine(S4) Packaging Detail:10g,50g,100g,500g,1kg in aluminum foil bags
Andarine(S4) Delivery Detail:5-7days for regular shipping
Usage:
Andarine (GTx-007, S-4) is an investigational selective androgen receptor modulator (SARM) developed by GTX, Inc for treatment of conditions such as muscle wasting, osteoporosis and benign prostatic hypertrophy, using the non-steroidal androgen antagonist bicalutamide as a lead compound.
Andarine is an orally active partial agonist for androgen receptors. It is less potent in both anabolic and androgenic effects than other SARMs. In an animal model of benign prostatic hypertrophy, andarine was shown to reduce prostate weight with similar efficacy to finasteride, but without producing any reduction in muscle mass or anti-androgenic side effects. This suggests that it is able to competitively block binding of dihydrotestosterone to its receptor targets in the prostate gland, but its partial agonist effects at androgen receptors prevent the side effects associated with the anti-androgenic drugs traditionally used for treatment of BPH.
Information of Andarine (S4) :
Andarine is an orally active partial agonist for androgen receptors, S-4 is effective in not only maintaining lean body mass but actually increasing it. Andarine is less potent in both anabolic and androgenic effects than other SARMs. In an animal model of benign prostatic hypertrophy, andarine was shown to reduce prostate weight with similar efficacy to finasteride, but without producing any reduction in muscle mass or anti-androgenic side effects. This suggests that it is able to competitively block binding to its receptor targets in the prostate gland, but its partial agonist effects at androgen receptors prevent the side effects associated with the anti-androgenic drugs traditionally used for treatment of BPH.
Other SARMs
Â
| Name | CAS NO. | Usage |
| AICAR | 2627-69-2 | acts by entering nucleoside pools, significantly increasing levels of adenosine during periods of ATP breakdown |
| MK2866 | 841205-47-8 | medical prescription for prevention of cachexia, atrophy, and sarcopenia and for Hormone or Testoserone Replacement Therapy. |
| MK-677 | 15972-10-0 | Â for the treatment of frailty in the elderly |
| LGD-4033 | 1165910-22-4 | pharmacological profile similar to that of enobosarm, Ostarine,MK-2866 |
| GW1516 | 317318-70-0 | For obesity, diabetes, dyslipidemia and cardiovascular disease |
| Andarine(S4) | 401900-40-0 | partial agonist, intended mainly for treatment of benign prostatic hypertrophy |
| SR9009 | 1379686-30-2 | under development at The Scripps Research Institute (TSRI), increases the level of metabolic activity in skeletal muscles of mice |
| RAD140 | 1182367-47-0 | New generation for gaining mass and cutting edges |
| YK11 | 431579-34-9 | YK11: a SARM and myostatin inhibitor in one  |
| AC262356 | 870888-46-3 | New SARMS |
| SR9011 | 1379686-29-9 | New SARMS |
| S23 | 1010396-29-8 | New SARMS |
| GW0724 | 317318-84-6 | New SARMS |
Â
Nano Stick Tape,Reusable Nano Tape,Traceless Adhesive Tape,Double Sided Gel Adhesive Tape
Kunshan Jieyudeng Intelligent Technology Co., Ltd. , https://www.jerrytape.com